Archive for December 13th, 2011
Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update
Posted by: admin on: December 13, 2011
Compared to other hypoglycemic GLP-1 analogs, injectable liraglutide marketed by Novo Nordisk has reiterated its position as an efficient and safe post prandial glycemic level controller. Here is the study. Team@CMHF
FDA Warns of Serious Risks Associated With Liraglutide
Posted by: admin on: December 13, 2011
Antidiabetic drug Liraglutide, reduces meal-related hyperglycemia (for 12 hours after administration) by increasing insulin secretion, delaying gastric emptying, and suppressing prandial glucagon secretion. But its safety is questionable since it is associated with pancreatitis, and increased calcitonin secretion associated with thyroid tumour in mice. Read on to know more. Team@CMHF
A little bit of exercise makes a big difference
Posted by: admin on: December 13, 2011
Busy schedule through the day keeps most of us away from exercising on a routine basis. ACSM has brought out a new book with guidelines for adults. Here are the salient points of this book .If you haven’t been exercising read on and get motivated. Team@CMHF
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
